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The diuretic drug amiloride was found to be a powerful inhibitor of the reaction of a~tylcholin~ter~ (AChE) and buty~lcholin~~~ (BChE) 
with their specific choline ester substrates. The inhibition constant is in the micromolar range. On the other hand, when added to a mixture of 
cholinesterase (AChE and BChE) and neutral substrates, amiloride, in some cases, enhanced the reaction rate. The rate of the reaction of butyryl- 
cholinesterase withpnitrophenyl butyrate was increased up to 12 fold by amiloride. 
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1. INTRODUCTION 
Acetylcholinesterase (AChE) and butyryl- 
cholinesterase (BCBE) have been extensively studied 
during the last five decades, and a great number of 
compounds have been investigated as substrates or in- 
hibitors of the enzymes. 
Interestingly, several quaternary nitrogen com- 
pounds of hydrophobic nature were found to be in- 
hibitory of the reaction between cholinesterases and 
their specific choline substrates, but also to induce 
enhanced reaction rate between the enzymes and non- 
ionic substrates or covalent inhibitors [l-7]. 
Here we report on the effect of the diuretic drug 
amiloride (Scheme 1) on the activity of AChE and 
BChE. 
Amiloride contains a heterocyclic hydrophobic acyl 
moiety, derived from pyrazine, to which a guanidinium 
group is attached (pK = 8.7). It was of interest to exa- 
mine whether the drug has au effect on the activity of 
cholinesterases. 
Amiloride is known as a powerful inhibitor of the 
H+/Na+ exchange with Ki = 0.3 pM [8,9]. Recently it 
has been found that the drug inhibits also other systems 
such as Na+/Ca’+ exchange with Xi = 10 FM [lo], 
phosphorylation by a variety of protein kinases with 
Ki = 0.1 mM [11,12] and phosphorylation of the 
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regulatory myosin light chain by myosin light chain 
kinase, Kr = 1 PM [13]. 
2. MATERIALS AND METHODS 
AChE (electric eel) and BChE (bovine serum) were products of 
Worthington and Sigma. Acetylcholine chloride, butyrylcholine 
iodide, p-nitrophenyl esters and amiloride were obtained from 
Sigma. 
2.1. Assay of enzyme activity 
To a solution of acetylcholine chloride or butyrylcholine iodide 
(1 mM in 10 ml containing 0.1 N NaCl) AChE (final concentration 
lo-” M) or BChE (final concentration lo-* M) was added. The reac- 
tion took place in the pH-stat at pH 7.5,25”C. The released protons 
were titrated with 0.05 N NaOH, and the reaction course was follow- 
ed by a recorder conjugated to the pH stat. 
The reactivity of cholinesterase with p-nitrophenyl esters (0.1 mM) 
was determined at pH 7.5 (0.1 M phosphate buffer, 2% v/v 
acetonitrile), 25°C and followed spectrophotometrically at400 nm. 
From the course of alkali uptake in the pH stat or from the absor- 
bance change in the spectrophotometer the reaction rate was 
calculated. 
2.2. Effect of amiloride 
Amiloride in different concentrations (0. l- 100 PM) was present in 
the reaction solution of enzyme and substrate, and the reaction rate 
was measured. In the case of inhibition the double reciprocal plot 
(l/v vs l/[q) or the Dixon plot (l/v vs inhibitor concentration) [14] 
yielded %:1, the inhibition constant. 
The effect of amiloride on the irreversible inactivation of AChE by 
methanesulfonyl f uoride (MSF) [I] was also studied. Enzyme solu- 
H,NAN’+NH, 
amiloride 
Scheme 1 
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tion was incubated with MSF (1 mM). At timed intervals an aliquot 
was removed and added to a substrate solution and the reaction rate 
measured. From the decline of enzyme activity the inactivation rate 
was calculated. 
3. RESULTS AND DISCUSSION 
When amiloride was added to a solution containing 
AChE and acetylcholine the enzymatic reaction was in- 
hibited. Analysis of the reaction kinetics indicated that 
the inhibition was competitive with KS = 5.5 f 0.5 PM. 
However, when amiloride was added to a solution con- 
taining AChE and the poor non-ionic substrate ethyl 
acetate, there was no marked effect on the reaction 
rate. On the other hand, the addition of amiloride to a 
solution of AChE with 1 mM of the covalent inhibitor 
MSF enhanced the rate of enzyme inactivation. 4 pM 
amiloride increased the inactivation rate by a factor of 
3. 
Amiloride was found to be a potent competitive in- 
hibitor of the reaction of BChE with butyrylcholine, 
with Ki = 0.95 f 0.1 FM. On the other hand, amiloride 
considerably enhanced the reaction rate between BChE 
and the neutral substrate p-nitrophenyl butyrate 
(pNPB). The effect of amiloride on activation of BChE 
is depicted in Fig. 1. Maximum rate enhancement is 
12 fold and it is achieved at approximately 10 pM of 
amiloride, whereas half maximal rate enhan~ment oc- 
curs at 1.1 pM amiloride. 
Amiloride affected also the reaction rate between 
BChE and a series of nitrophenyl ester derivatives of 
various acids, but the rate enhancement was smaller 
than that found with pNPB (Table I). 
The fact that amiloride is a competitive in~bitor of 
the reaction between acetylcholine and AChE suggests 
that the guanidinium group of the inhibitor occupies 
the anionic site of the enzyme, thus excluding from it 
the cationic moiety of the substrate. The finding that 
amiloride enhances the rate of the covalent inhibition 
of AChE by MSF implies that, in the ternary complex 
AChE-amiloride-MSF formed, binding of amiloride in- 
duces conformational change of the enzyme which 
leads to the increased rate of inhibition by MSF. 
Rate enhancement of covalent inhibition of AChE 
induced by binding of quaternary ammonium 
derivatives has been described in the literature. Wilson 
and coworkers showed that the tetraethyl ammonium 
cation increased the rate of AChE inhibition by MSF 
up to 33 fold [l]. In the presence of tetramethyl am- 
monium salt the rate of inhibition of AChE by 
dimethylc~bamoyl fluoride was increased up to 
14 fold 121. 
It is interesting that quaternary ammonium 
derivatives were found in few cases to accelerate the in- 
hibition of AChE caused by chemical modification of 
amino acid residues outside the active site of the en- 
zyme. Thus, Wilson and Silman demonstrated that 
pyridine-Zaldoxime methiodide (ZPAM) dramatically 
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Fig. 1. Amiloride induced activation of the reaction between BChE 
and pNPB (0.1 mM) at pH 7.5, 2YC. The rate is expressed in the 
change of optical density units at 400 nm/min. 
accelerated the rate of inhibition of AChE by arsenite, 
with maximum enhancement of 220 fold [3]. 
Blumberg and Silman found that 0.1 mM methyl 
pyridinium increased several fold the rate of inhibition 
of AChE caused by ~-hydroxysu~~i~mide ester of N- 
a~etyl-~-(2,4-dinitroa~lino)-~-phenyl~a~ne. A 
tyrosine residue was modified by the ester [4]. The ef- 
fect of quaternary ammonium salts on AChE catalyzed 
hydrolysis of substrates has also been reported in the 
literature. Metzger and Wilson showed that 3 mM 
tetraethyl a~onium provided 3-fold acceleration of 
acetyl fluoride [5]. Bartlett and Rosenburry found that 
l-methyl acridinium induced j-fold enhancement of the 
rate of ethyl acetate hydrolysis by AChE [6]. Desire and 
Saint-Andre have studied the effect of a series of 
quaternary ammonium heterocyclic compounds on 
AChE catalyzed hydrolysis of alkyl acetates. The 
largest rate enhancement, 6.5 fold, occurred where N- 
methyl benzo-7,&quinolinium was added to a solution 
containing AChE and ethyl acetate [7]. 
The finding that amiloride can accelerate the inac- 
tivation of AChE by MSF adds the gua~dinium moiety 
to the ligands which on binding to the enzyme enhance 
its activity. 
The effect of amiloride on BChE was more pro- 
nounced than that on AChE. Amiloride inhibited the 
Table I 
Ratio (r) of the rate of reaction between BChE and 0.1 mM substrate 
in the presence of 4 FM amiloride to the rate of the same reaction 
without the drug, at pH 7.5, 25’C 
Substrate 
pNP acetate 
pNP propionate 
pNP butyrate 
pNP pentanoate 
pNP hexanoate 
pNP octanoate 
oNP acetate 
oNP butyrate 
a r c 1 indicates inhibition 
? 
2.6 
3.8 
8.5 
4.4 
2.1 
1.5 
0.6 
0.4 
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BChE catalyzed hydrolysis of butyrylcholine with Ki = 
0.95 + 0.1 ,uM, compared with Ki = 5.5 rt: 0.5 yM for 
the parallel reaction of AChE with acetylcholine. 
Amiloride increased the rate of the BChE catalyzed 
hydrolysis of pNPB by a factor of 12 at 10 ,uM ligand 
(Fig. 1). The amiloride concentration which causes half 
maximal increase is 1.1 PM, which is very similar to the 
value of Ki for amiloride inhibition of the reaction of 
BChE with butyrylcholine. This suggests that both as 
an inhibitor and activator amiloride binds to the same 
site in the enzyme. Amiloride probably occupies the site 
to which the choline cation is bound, whereas pNPB is 
bound to a different site. In the ternary complex BChE- 
amiloride-pNPB the enzyme is much more active than 
in the binary complex BChE-pNPB. 
Desire and Saint-Andre have studied the effect of 
several quaternary heterocyclic compounds on BChE 
catalyzed hydrolysis of alkyl acetates. The most effec- 
tive ligand was N-methyl-7,8-quinolinium cation, 
which at 5 PM enhanced the hydrolysis rate of ethyl 
acetate by 7.5-fold [7]. 
Table I shows that amiloride affects the hydrolysis 
rate of pNPB by BChE to a greater extent than the 
reaction rates of other pNP esters. Probably binding of 
pNPB to BChE-amiloride fits best the orientation re- 
quired for enhancing the enzyme activity. Binding of 
lower or higher homologues of pNPB to BChE- 
amiloride complex does not produce the optimal orien- 
tation for enzyme activity. 
Inspection of Table I shows that BChE catalyzed 
hydrolysis of oNP esters is inhibited by amiloride in 
contrast to the enhanced hydrolysis rate of the pNP 
ester isomers. A change of the position of the nitro 
group in the phenyl moiety from para to ortho prevents 
the ester from binding to the enzyme-amiloride com- 
plex. Thus, in BChE-amiloride the enzyme ‘senses’ 
small structural changes of ligands. 
Our reported results suggest hat when the diuretic 
drug amiloride is studied in physiological systems its 
possible effect on cholinesterase should not be ignored. 
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